High-throughput screening identifies CHMP4A associated with hypoxia-inducible factor 1

Area of Science:

• Molecular Biology
• Cancer Research
• Cellular Hypoxia

Background:

• Tumor hypoxia is prevalent in solid tumors.
• Hypoxia-inducible factor-1 (HIF-1) is a key transcription factor regulating cellular response to low oxygen.
• HIF-1 overexpression is linked to tumor progression, angiogenesis, invasion, and drug resistance.

Purpose of the Study:

• To identify novel human genes influencing the stability and transcriptional activity of HIF-1.
• To develop a high-throughput screening platform for HIF-1-related genes.

Main Methods:

• A dual luciferase reporter system utilizing a hypoxia-responsive element was employed.
• 409 novel human genes were screened.
• Western blot and RT-PCR were used to analyze HIF-1α protein and adenylate kinase 3 (a HIF-1 target gene) transcription levels, respectively.

Main Results:

• Chromatin-modifying protein 4A significantly upregulated HIF-1 activity in both normoxic and hypoxic conditions.
• Chromatin-modifying protein 4A increased HIF-1α protein expression under normoxia.
• Chromatin-modifying protein 4A enhanced the transcription of adenylate kinase 3.

Conclusions:

• The developed functional screening platform is effective for high-throughput screening of HIF-1-related genes.
• These findings provide novel insights into the molecular mechanisms governing hypoxia in mammalian cells.
• Chromatin-modifying protein 4A emerges as a potential regulator of HIF-1 pathway.